PI
AMLX icon

PEAK6 Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History

PEAK6 Investments’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30,000
Closed -$442K – 3966
2023
Q4 		$442K Buy
+30,000
New +$460K ﹤0.01% 2710
2023
Q3 		– Sell
-17,700
Closed -$382K – 4016
2023
Q2 		$382K Sell
17,700
-3,000
-14% -$81K ﹤0.01% 2404
2023
Q1 		$607K Buy
+20,700
New +$719K ﹤0.01% 2245
2022
Q4 		– Sell
-54,800
Closed -$1.54M – 4364
2022
Q3 		$1.54M Buy
54,800
+37,100
+210% +$926K 0.01% 1795
2022
Q2 		$382K Buy
+17,700
New +$210K ﹤0.01% 4122

Other funds holding AMLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PEAK6 Investments's AMLX Position: Q3 2023 in Review

PEAK6 Investments sold out of Amylyx Pharmaceuticals (AMLX) in Q3 2023, closing a stake of 1,500 shares — an estimated $32.4K sold.

PEAK6 Investments first reported a position in AMLX in Q2 2022 and held it in 2 quarters. The position peaked at $32.4K in Q2 2023. 170 funds tracked by Wall St. Rank hold AMLX as of Q3 2023.

  • PEAK6 Investments reported no remaining Amylyx Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 1,500 Amylyx Pharmaceuticals shares in Q3 2023, an estimated $32.4K.
  • PEAK6 Investments first reported a position in Amylyx Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • PEAK6 Investments's Amylyx Pharmaceuticals position peaked at $32.4K in Q2 2023.
  • 170 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.